Panel Business of Biotech track
Voices from the IPO Class of ’25/’26: What’s Next?
Mon, Nov 9, 2026 · 2:00–2:45 PM CET Business of Biotech Stage, Koelnmesse
About this session
The biotech IPO class of 2025 and 2026 has been nothing short of transformative, ushering in a wave of innovation and ambition. But what happens after the confetti settles and the headlines fade? In this compelling panel, hear directly from the trailblazers who took their companies public and are now navigating the next chapter of their journey. From overcoming market hurdles to scaling breakthroughs, these leaders will share the untold stories of resilience, vision, and the bold steps they’re taking to shape the future of biotech.
